Latest Content

The FDA has withdrawn its accelerated approval of Krazati combined with Erbitux for adults with KRAS G12C-mutated colorectal cancer that is locally advanced or has spread to other parts of the body.

Dr. Diego Schaps discussed how upcoming Medicare competitive bidding changes could affect access to ostomy supplies and why having the right pouching system matters for patients.

Dr. Andrew Ip answers common lymphoma questions, from diagnosis and treatment options to CAR T-cell therapy, side effects and hope for patients.

Bristol Myers Squibb reports positive results from a phase 2 trial of investigational CAR T-cell therapy arlo-cel in relapsed multiple myeloma.

Hargitay shared her thoughts with CURE regarding her father’s journey, her motivation for speaking out now, and the key message she wants to convey to patients today.

A new study found alcohol-attributable cancer deaths in the U.S. rose from 11,361 in 1990 to 23,126 in 2023, with men and older adults most affected.

Cancer survivor Brynn Forlizzi and caregiver Teddy Aaron created Soothe Note, an app designed to help cancer patients and caregivers manage care.

My multiple myeloma nurse case manager sat in on every appointment, helped me appeal an insurance denial and made sure I never felt like just a number.

Dr. Doured Daghistani discusses how childhood cancer treatment, survivorship care and immunotherapy have evolved this Childhood Cancer Awareness Month.

Explore how personalized treatment, immunotherapy, AI and other advances are transforming cancer care, with insights from Dr. Manmeet Ahluwalia.

Dr. Doured Daghistani explains how pediatric oncology is shifting toward reducing long-term side effects as childhood cancer survival rates rise.

Two and a half years into cancer treatment, my nurse Jenny Gnoza still greets me with a smile, steadies my nerves and finds the vein everyone else misses.

AI is changing breast cancer screening, helping doctors detect cancer and predict future risk. Learn what AI mammography means for patients.